Pegasus Farmaco (India) Private Limited, a active private limited company, was established on 18 October 1995 in Andhra Pradesh, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1995PTC022036. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.65 Cr and a paid-up capital of ₹4.47 Cr.
It upholds a compliant status. Employing 127 professional, Its leadership includes Raghuveer Beti (Managing Director), Neeraja Beti (Director). Past directors included Vodela Mallikarjun, Vuthoori Surender, Vuthoori Indira. It holds ₹18.06 Cr open charges and ₹14.79 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 1-3-183/40/B/1, S.B.I Colonygandhi Nagar Hyderabad-500 080., Andhra Pradesh, Telangana, 500080.
U24230TG1995PTC022036
022036
18 October 1995
₹7.65 Cr
₹4.47 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Pegasus Farmaco (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghuveer Beti | Managing Director | 12 Apr 2004 | Current |
| Neeraja Beti | Director | 30 Sep 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 16 Oct 2023 | Past |
| Pramod Abcsdd | Director | 04 Mar 2022 | Past |
| Pramod Abcsdd | Director | 04 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pegasus Farmaco (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 34.27% decrease. The company also saw a substantial fall in profitability, with a 12.97% decrease in profit. The company's net worth moved up by a moderate rise of 4.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Pegasus Farmaco (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹180,627,000.00
₹147,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2019 | Others | ₹18.06 Cr | Open |
| 14 May 2007 | State Bank Of India | ₹12.69 Cr | Satisfied |
| 26 Oct 2005 | Punjab National Bank | ₹1.90 Cr | Satisfied |
| 07 May 2003 | City Union Bank Ltd. | ₹1.00 M | Satisfied |
| 20 Jul 1998 | State Bank Of Hyderabad | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Pegasus Farmaco (India) has a workforce of 127 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pegasus Farmaco (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pegasus Farmaco (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 18.06 Cr registered on 20 Jul 2019 with Charge ID 100284357 was modified on 27 Mar 2023. was documented.
The activity Pegasus Farmaco (India) Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
Pegasus Farmaco (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was recorded as a recent event.
The activity A charge registered on 14 May 2007 via Charge ID 10057413 with State Bank Of India was fully satisfied on 14 Aug 2019. was completed.
The activity A charge with Others amounted to Rs. 18.06 Cr with Charge ID 100284357 was registered on 20 Jul 2019. was completed.
The activity A charge with State Bank Of India of Rs. 12.69 Cr registered on 14 May 2007 with Charge ID 10057413 was modified on 18 Sep 2012. was completed.
The CIN of Pegasus Farmaco (India) Private Limited is U24230TG1995PTC022036.
Pegasus Farmaco (India) Private Limited is headquartered at 1-3-183/40/B/1, S.B.I Colonygandhi Nagar Hyderabad-500 080., Andhra Pradesh, Telangana, 500080.
Pegasus Farmaco (India) Private Limited was incorporated on 18 October 1995.
The current directors of Pegasus Farmaco (India) Private Limited are
The primary industry of Pegasus Farmaco (India) Private Limited is Manufacturing.
Pegasus Farmaco (India) Private Limited is unlisted.
The authorized capital of Pegasus Farmaco (India) Private Limited is ₹7.65 Cr, and the paid-up capital is ₹4.47 Cr.
The compliance status of Pegasus Farmaco (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX